1. Surgical Value Analysis Committee
August 1, 2017
Presenters:
Sandy Myint & Mari Machado

2. Surgical Value Analysis Value Analysis Definition
“A systematic process to review clinical products, equipment and technologies to evaluate their clinical efficacy, safety and impact on organizational resources”.
Source: Association Healthcare Value Analysis Professionals
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

3. Value = Quality (Safety ,Service,& Outcomes)
Surgical Value Analysis Value Analysis alignment to Triple Aim in Healthcare Value Based Purchasing
Value = Quality (Safety ,Service,& Outcomes)
Cost
Value –Improving Health of populations
Quality –Improving the patient – experience of care (including quality and satisfaction)
Cost - Reducing the per capita cost of healthcare
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

4. Surgical Value Analysis Value Analysis Mission Statement
The Value Analysis Program will provide resolution for existing and/or new product requests that could significantly increase financial liability to the organization; impact efforts to standardize product use and practice; identify conflicts of interest and vendor relationships with requestors; and affect a broad range of clinical areas with significant impact on patient quality and outcomes.
Ultimately, product selection will be based on clinical evidence and recognized best practices to drive excellent outcomes.
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

5. Surgical Value Analysis Process to achieve goals
Apply a methodology to address utilization, standardization, and operational practices
Utilization review - DRG and procedure based assessment
Contract review - spend and compliance assessment
Utilize established criteria for determining priority
Perform risk assessment
Perform clinical review
Perform financial review
Transparent decision making by the VA team
Monitor and track decision outcomes
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

6. Surgical Value Analysis
Collaborative Process for Contracting 3
End user & supplier communication throughout phases of contract award process
Use national databases to identify projects -best practice pricing/usage
VA teams validate our price / utilization and relevant clinical data
Teams ensure that quality is maintained or improved
Opportunity & recommendation is presented to clinicians and physicians for feedback and validation
Value Analysis team decision & contract award 4 2 1 5
Heather
ECRI Price Guide; Crimson, GPO, Networking
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

7. Surgical Value Analysis
Focus
Projects
Implementation
And Conversion
New Product Introduction to Supply Chain Formulary
System Wide
Multidisciplinary
Types
Utilization
Standardization
Waste Reduction
Impact
Reduce Practice Variation
Quality and Safety
Outcomes
Cost Reduction
New Products
Requests
Releases
New Procedure
New Clinicians
Product issues
Regulations
Coordination System Wide
Communication
Education
Monitor
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

8. Surgical Value Analysis
Physician and Clinical practitioner engagement is critical !
Open Dialog
Implementation
Subject Matter Experts
Negotiations
Team work
Collaborative Environment
Practice/ Evidence/ Finance
Medical Devices/ Technology
Physician & Clinical Champions
Data Review and Interpretation
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

9. Data Sources are variable across our Organization
Surgical Value Analysis Data Sources to incorporate into Value Analysis
Data Sources are variable across our Organization
Patient Bill Data
Supply Cost File
Patient Discharge
All Payor Data
Closed Receipt File
Spend
Market Share
Acquisition Cost
Profitability
Cost per Case
Outcomes
Surgical Data
Procedure Log
Implant Log
OR/Procedural Data
Procedure Time
Procedure Volume Product Utilization
Quality Data
Infection Control Data
Patient Experience
Quality Data
LOS
Readmissions
HAI rates
HCAPS
Nation Benchmarks
Clinical Benchmarks
Financial Benchmarks
Crimson*
ECRI*
Benchmark data
Technology review Clinical evidence
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth. 12 3 3

10. Surgical Value Analysis
Collaboration
PRODUCT USERS
(Product knowledge & evaluation)
Supply Chain
(Vendor mgmnt & contracting knowledge)
FINANCE
(Cost-benefit knowledge)
Value Analysis Program
(Review & Evaluation)
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

11. Surgical Value Analysis
Work Group & Committee Structure
New Technology
Assessment
Pharmacy
Clinical Research
Surgery
Clinical and
Nursing
Oversight
Committee
Clinical Leadership
Imaging
(MRI, CT, Diagnostic, Mammography)
Cardiovascular Services
Lab Services
(Lab)
Support Services

12. Surgical Value Analysis Work Group & Committee Structure (expanded)
Pulmonary/ Respiratory
Advanced Wound Care
New Technology
Assessment
Ortho Trauma & Ortho Oncology
Pharmacy
Brain & Spine
Pain Management
Clinical Research
Ophthalmology
ENT/ Plastic
Surgery
Clinical and
Nursing
Imaging
Lab Services
(Lab)
Support Services
Oversight
Committee
Clinical Leadership
Cardiovascular Services
Infection Prevention
Critical Care and ED
Anesthesia
Sports Medicine
Gyn/Urology
GI/Endoscopy Lab
CSPD
Structural Heart
Electro Physiology
Cardiovascular Surgery
Vascular Surgery
Interventional Radiology
Invasive Cardiology
Non-Invasive
Cardiology
Neuro vascular

13. Surgical Value Analysis New Product Request Form-Clinician
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

14. Surgical Value Analysis New Product Request Form-Vendor
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

15. Surgical Value Analysis New Product Request (NPR) Guidelines
1) All NPR’s must be completely filled out before it will be accepted for review.
2) All NPR’s are required to be reviewed & signed by department director.
3) All NPR’s need to be received in the VA mailbox no later than 14 days prior to the next committee meeting in order to be presented.
4) Requestors, be it physician or clinical staff, will be required to present at the committee meeting.
5) Emergency NPR’s will be determined by the department director and will need to follow all other guidelines as listed & would be presented at the following committee meeting.
6) All requests for evaluations, new products, services, and capital should go through the VA process.
7) Work groups, made up of clinicians, physicians & other appropriate members, will be by service line &/or ad hoc by project. Members will vote and decisions will be reported up to the appropriate committee.
8) All decisions ,may be appealed once per year through the appropriate committee.
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

16. Surgical Value Analysis New Product Request Flow Chart
Make product available for use
Completed NPR Received in VA
Shared with Sourcing for Assignment
Place order for product & receive
Conduct Clinical & Financial Analysis
Enter product information into purchasing system & assign CDM
Sourcing works on evaluation or contract terms & conditions
Presented in Service Line or Ad Hoc Work Group
Evaluation, Contract or Denial
**There will be some variation when dealing with implants, capital and services.
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.

17. Surgical Value Analysis
Glossary of Terms
Any and all information discussed or implied during this meeting and discussion as it relates to the vendors, products, pricing, strategy and/or market share are considered privileged and confidential information and cannot be shared at any time outside of University of Miami & UHealth.